MDA SPACE LTD (MDA.CA) Stock Fundamental Analysis
Canada - TSX:MDA - CA55293N1096 - Common Stock
22.26 CAD
+0.83 (+3.87%)
We assign a fundamental rating of 6 out of 10 to MDA. MDA was compared to 11 industry peers in the Aerospace & Defense industry. While MDA has a great profitability rating, there are some minor concerns on its financial health. MDA is growing strongly while it also seems undervalued. This is an interesting combination These ratings would make MDA suitable for value and growth investing!
1. Profitability
1.1 Basic Checks
MDA had positive earnings in the past year.
MDA had a positive operating cash flow in the past year.
Of the past 5 years MDA 4 years were profitable.
MDA had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 3.63%, MDA belongs to the top of the industry, outperforming 90.91% of the companies in the same industry.
MDA has a better Return On Equity (8.94%) than 100.00% of its industry peers.
Looking at the Return On Invested Capital, with a value of 5.72%, MDA is in line with its industry, outperforming 45.45% of the companies in the same industry.
MDA had an Average Return On Invested Capital over the past 3 years of 3.99%. This is below the industry average of 8.50%.
The 3 year average ROIC (3.99%) for MDA is below the current ROIC(5.72%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.63% | ||
| ROE | 8.94% | ||
| ROIC | 5.72% |
ROA(3y)2.27%
ROA(5y)1.16%
ROE(3y)4.65%
ROE(5y)2.1%
ROIC(3y)3.99%
ROIC(5y)N/A
1.3 Margins
The Profit Margin of MDA (8.48%) is better than 90.91% of its industry peers.
In the last couple of years the Profit Margin of MDA has grown nicely.
Looking at the Operating Margin, with a value of 10.97%, MDA is in line with its industry, outperforming 45.45% of the companies in the same industry.
MDA's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 24.54%, MDA is in the better half of the industry, outperforming 72.73% of the companies in the same industry.
MDA's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.97% | ||
| PM (TTM) | 8.48% | ||
| GM | 24.54% |
OM growth 3Y34.46%
OM growth 5YN/A
PM growth 3Y129.51%
PM growth 5YN/A
GM growth 3Y-9.5%
GM growth 5YN/A
2. Health
2.1 Basic Checks
MDA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, MDA has more shares outstanding
MDA has a better debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 1.50, we must say that MDA is in the distress zone and has some risk of bankruptcy.
MDA's Altman-Z score of 1.50 is amongst the best of the industry. MDA outperforms 81.82% of its industry peers.
The Debt to FCF ratio of MDA is 0.55, which is an excellent value as it means it would take MDA, only 0.55 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of MDA (0.55) is better than 100.00% of its industry peers.
MDA has a Debt/Equity ratio of 0.29. This is a healthy value indicating a solid balance between debt and equity.
With an excellent Debt to Equity ratio value of 0.29, MDA belongs to the best of the industry, outperforming 81.82% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.29 | ||
| Debt/FCF | 0.55 | ||
| Altman-Z | 1.5 |
ROIC/WACC0.63
WACC9.04%
2.3 Liquidity
MDA has a Current Ratio of 0.86. This is a bad value and indicates that MDA is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.86, MDA is doing worse than 72.73% of the companies in the same industry.
A Quick Ratio of 0.85 indicates that MDA may have some problems paying its short term obligations.
The Quick ratio of MDA (0.85) is better than 72.73% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.86 | ||
| Quick Ratio | 0.85 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 185.37% over the past year.
The Earnings Per Share has been growing by 185.75% on average over the past years. This is a very strong growth
Looking at the last year, MDA shows a very strong growth in Revenue. The Revenue has grown by 57.21%.
Measured over the past years, MDA shows a very strong growth in Revenue. The Revenue has been growing by 31.32% on average per year.
EPS 1Y (TTM)185.37%
EPS 3Y185.75%
EPS 5YN/A
EPS Q2Q%322.22%
Revenue 1Y (TTM)57.21%
Revenue growth 3Y31.32%
Revenue growth 5YN/A
Sales Q2Q%54.26%
3.2 Future
MDA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 34.67% yearly.
The Revenue is expected to grow by 23.76% on average over the next years. This is a very strong growth
EPS Next Y107.77%
EPS Next 2Y49.97%
EPS Next 3Y34.67%
EPS Next 5YN/A
Revenue Next Year52.07%
Revenue Next 2Y31.15%
Revenue Next 3Y23.76%
Revenue Next 5YN/A
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 19.03 indicates a rather expensive valuation of MDA.
Compared to the rest of the industry, the Price/Earnings ratio of MDA indicates a somewhat cheap valuation: MDA is cheaper than 72.73% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 25.89, MDA is valued a bit cheaper.
MDA is valuated correctly with a Price/Forward Earnings ratio of 14.14.
Compared to the rest of the industry, the Price/Forward Earnings ratio of MDA indicates a somewhat cheap valuation: MDA is cheaper than 72.73% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 34.59. MDA is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.03 | ||
| Fwd PE | 14.14 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MDA indicates a somewhat cheap valuation: MDA is cheaper than 63.64% of the companies listed in the same industry.
72.73% of the companies in the same industry are more expensive than MDA, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 3.96 | ||
| EV/EBITDA | 10.33 |
4.3 Compensation for Growth
MDA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of MDA may justify a higher PE ratio.
MDA's earnings are expected to grow with 34.67% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.18
PEG (5Y)N/A
EPS Next 2Y49.97%
EPS Next 3Y34.67%
5. Dividend
5.1 Amount
No dividends for MDA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX:MDA (11/14/2025, 7:00:00 PM)
22.26
+0.83 (+3.87%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)
Earnings (Next)
Inst Owners32.56%
Inst Owner ChangeN/A
Ins Owners1.18%
Ins Owner ChangeN/A
Market Cap2.81B
Revenue(TTM)1.35B
Net Income(TTM)114.70M
Analysts78.33
Price Target44.43 (99.6%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)21.62%
Min EPS beat(2)21.08%
Max EPS beat(2)22.16%
EPS beat(4)4
Avg EPS beat(4)29.79%
Min EPS beat(4)19.18%
Max EPS beat(4)56.74%
EPS beat(8)7
Avg EPS beat(8)31.88%
EPS beat(12)11
Avg EPS beat(12)88.39%
EPS beat(16)14
Avg EPS beat(16)87.43%
Revenue beat(2)1
Avg Revenue beat(2)3.32%
Min Revenue beat(2)-0.24%
Max Revenue beat(2)6.87%
Revenue beat(4)3
Avg Revenue beat(4)3.78%
Min Revenue beat(4)-0.24%
Max Revenue beat(4)7.65%
Revenue beat(8)5
Avg Revenue beat(8)3.09%
Revenue beat(12)9
Avg Revenue beat(12)2.82%
Revenue beat(16)10
Avg Revenue beat(16)0.84%
PT rev (1m)1.48%
PT rev (3m)-10.31%
EPS NQ rev (1m)-0.99%
EPS NQ rev (3m)-6.83%
EPS NY rev (1m)-1.23%
EPS NY rev (3m)22.24%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.09%
Revenue NY rev (1m)-0.12%
Revenue NY rev (3m)-0.25%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.03 | ||
| Fwd PE | 14.14 | ||
| P/S | 2.07 | ||
| P/FCF | 3.96 | ||
| P/OCF | 2.92 | ||
| P/B | 2.19 | ||
| P/tB | 11.05 | ||
| EV/EBITDA | 10.33 |
EPS(TTM)1.17
EY5.26%
EPS(NY)1.57
Fwd EY7.07%
FCF(TTM)5.62
FCFY25.24%
OCF(TTM)7.63
OCFY34.27%
SpS10.73
BVpS10.17
TBVpS2.01
PEG (NY)0.18
PEG (5Y)N/A
Graham Number16.36
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.63% | ||
| ROE | 8.94% | ||
| ROCE | 7.95% | ||
| ROIC | 5.72% | ||
| ROICexc | 8.9% | ||
| ROICexgc | 61.78% | ||
| OM | 10.97% | ||
| PM (TTM) | 8.48% | ||
| GM | 24.54% | ||
| FCFM | 52.35% |
ROA(3y)2.27%
ROA(5y)1.16%
ROE(3y)4.65%
ROE(5y)2.1%
ROIC(3y)3.99%
ROIC(5y)N/A
ROICexc(3y)4.25%
ROICexc(5y)N/A
ROICexgc(3y)14.8%
ROICexgc(5y)N/A
ROCE(3y)5.54%
ROCE(5y)N/A
ROICexgc growth 3Y59.28%
ROICexgc growth 5YN/A
ROICexc growth 3Y71.38%
ROICexc growth 5YN/A
OM growth 3Y34.46%
OM growth 5YN/A
PM growth 3Y129.51%
PM growth 5YN/A
GM growth 3Y-9.5%
GM growth 5YN/A
F-Score6
Asset Turnover0.43
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.29 | ||
| Debt/FCF | 0.55 | ||
| Debt/EBITDA | 1.52 | ||
| Cap/Depr | 262.11% | ||
| Cap/Sales | 18.71% | ||
| Interest Coverage | 8.48 | ||
| Cash Conversion | 392.53% | ||
| Profit Quality | 617.7% | ||
| Current Ratio | 0.86 | ||
| Quick Ratio | 0.85 | ||
| Altman-Z | 1.5 |
F-Score6
WACC9.04%
ROIC/WACC0.63
Cap/Depr(3y)234.8%
Cap/Depr(5y)169.15%
Cap/Sales(3y)23.53%
Cap/Sales(5y)18.99%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)185.37%
EPS 3Y185.75%
EPS 5YN/A
EPS Q2Q%322.22%
EPS Next Y107.77%
EPS Next 2Y49.97%
EPS Next 3Y34.67%
EPS Next 5YN/A
Revenue 1Y (TTM)57.21%
Revenue growth 3Y31.32%
Revenue growth 5YN/A
Sales Q2Q%54.26%
Revenue Next Year52.07%
Revenue Next 2Y31.15%
Revenue Next 3Y23.76%
Revenue Next 5YN/A
EBIT growth 1Y115.07%
EBIT growth 3Y76.57%
EBIT growth 5YN/A
EBIT Next Year179.33%
EBIT Next 3Y51.75%
EBIT Next 5YN/A
FCF growth 1Y1778.91%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y628.56%
OCF growth 3Y124.48%
OCF growth 5YN/A
MDA SPACE LTD / MDA.CA FAQ
What is the fundamental rating for MDA stock?
ChartMill assigns a fundamental rating of 6 / 10 to MDA.CA.
What is the valuation status for MDA stock?
ChartMill assigns a valuation rating of 7 / 10 to MDA SPACE LTD (MDA.CA). This can be considered as Undervalued.
What is the profitability of MDA stock?
MDA SPACE LTD (MDA.CA) has a profitability rating of 7 / 10.
What is the valuation of MDA SPACE LTD based on its PE and PB ratios?
The Price/Earnings (PE) ratio for MDA SPACE LTD (MDA.CA) is 19.03 and the Price/Book (PB) ratio is 2.19.